The Analysis and Control of Less Desirable Flavors in Foods and Beverages || RECENT ADVANCES IN THE SEPARATION OF VOLATILE COMPONENTS
- 作者Jennings, Walter
- 文件大小657.27KB
- 发表时间1980
- DOI10.1016/b978-0-12-169065-6.50007-6
- 页码3-16
Deregulation and cross talk among Sonic hedgehog, Wnt, Hox and Notch signaling in chronic myeloid leukemia progressionSengupta, A; Banerjee, D; Chandra, S; Banerji, S K; Ghosh, R; Roy, R; Banerjee, S · Leukemia · 2007
Mast Cell Stabilization and Membrane Protection Activity of Barleria prionitis L.Maji, A.K.; Bhadra, S.; Mahapatra, S.; Banerji, P.; Banerjee, D. · Pharmacognosy Journal · 2011
1055PClinical impact of molecular profiling of cervical cancer (CC) patients (pts) in a dedicated phase I (P1) unitScaranti, M; Caldwell, R; Miralles, M Selvi; Shinde, R; Pal, A; Ang, J E; Biondo, A; Guo, C; Cojocaru, E; Gennatas, S; Lockie, F; Bertan, C; Baker, C; Carreira, S; Banerjee, S; Kaye, S; de Bono, J S; Banerji, U; Minchom, A; Lopez, J · Annals of Oncology · 2019
993OOCTOPUS: A randomised, multi-centre phase II umbrella trial of weekly paclitaxel+/- novel agents in platinum-resistant ovarian cancer: VistusertibBanerjee, S; Lewsley, L-A; Clamp, A R; krell, J; Herbertson, R; Glasspool, R M; Orbegoso, C; Green, C; Kristeleit, R S; Gourley, C; Cambell, C; Banerji, U; Shepherd, C; Brugger, W; Chudleigh, L; Hanif, A; McNeish, I A; Paul, J · Annals of Oncology · 2019
L11.06 * HUMAN CANCER CELLS ISOLATED FROM ASCITES AS MODELS TO OPTIMIZE THE USE OF TARGETED ANTICANCER AGENTS IN OVARIAN CANCERBanerji, U.; Stewart, A.; Thavasu, P.; Banerjee, S.; Kaye, S. B. · Annals of Oncology · 2013
468PPHASE I MULTICENTRE TAX-TORC TRIAL OF THE DUAL MTORC1/2 INHIBITOR AZD2014 (A) PLUS WEEKLY PACLITAXEL (P) IN PATIENTS (PTS) WITH SOLID TUMOURS (CRUKD/12/013)Basu, B.; Roda-Perez, D.; Wong, H.H.; Sathiyayogan, N.; Parmar, M.; Turner, A.; Swales, K.; Stimpson, S.; Hall, E.; Hategan, M.; Garcia-Corbacho, J.; Yap, T.A.; Molife, L.R.; Jimenez, B.; Banerjee, S.; Kaye, S.B.; De Bono, J.S.; Banerji, U. · Annals of Oncology · 2014
Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancerBasu, B; Krebs, M G; Sundar, R; Wilson, R H; Spicer, J; Jones, R; Brada, M; Talbot, D C; Steele, N; Ingles Garces, A H; Brugger, W; Harrington, E A; Evans, J; Hall, E; Tovey, H; de Oliveira, F M; Carreira, S; Swales, K; Ruddle, R; Raynaud, F I; Purchase, B; Dawes, J C; Parmar, M; Turner, A J; Tunariu, N; Banerjee, S; de Bono, J S; Banerji, U · Annals of Oncology · 2018
Electron-microwave interactionsWatt, F · Journal of Physics A: General Physics · 1972
Group algebras and tensor operatorsKillingbeck, J · Journal of Physics A: General Physics · 1972
Fluid order and freezingHutchinson, P; Ross, M; Schofield, P; Conkie, W R · Journal of Physics A: General Physics · 1971
Complementary bounds for dynamic polarizabilitiesRobinson, P D · Journal of Physics A: General Physics · 1969
Interaction theory and Lagrangian electrodynamicsLeiter, D · Journal of Physics A: General Physics · 1970
Position observables for relativistic systemsLunn, M · Journal of Physics A: General Physics · 1968
Zitterbewegung as a subdynamicsRae, J · Journal of Physics A: General Physics · 1972
Lower bounds to expectation valuesWeinhold, F · Journal of Physics A: General Physics · 1968